Skip to content
S1758Senate2023-2024 Session

Classify W-18 as Controlled Substance

Official title

“Relates to adding W-18 to the schedule of controlled substances”

Sponsor James SkoufisSD-42Affects Health
Status
In Senate Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill adds W-18 to New York’s list of Schedule I controlled substances.

Why it matters

  1. Statewide reach. The classification would apply throughout New York under the public health law.

  2. Targeted change. The bill adds W-18 by name and chemical description to Schedule I, without changing other listed substances.

  3. Immediate effect. The new classification would take effect immediately upon enactment.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Health regulators

    The bill would add W-18 to the controlled-substance schedule in the public health law they administer.

  • Law enforcement agencies

    The listing would place W-18 within New York’s Schedule I controlled-substance framework.

  • People handling W-18

    They would need to account for its new classification as a Schedule I controlled substance.

Headline styles

Classify W-18 as Controlled Substance

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 42

Chair, Investigations And Government Operations

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1758

2023-2024 Regular Sessions

IN SENATE

January 13, 2023

Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to adding W-18 to the schedule of controlled substances

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (b) of schedule I of section 3306 of the public health law is amended by adding a new paragraph 71 to read as follows:

(71) W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinylidene}benzenesulfonamide).

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04676-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to adding W-18 to the schedule of controlled substances

Purpose

Relates to adding W-18 to the schedule of controlled substances.

Summary of provisions

Section 1: adds W-18 (4-chloro-N-(1-{2-(4-nitrophenyflethy1}2- piperidinylidenelbenzenesulfonamide to Subdivision (b) of Schedule I of Section 3306 of the Public Health Law.

Section 2: Sets effective date.

Justification

In recent years, the use of synthetic drugs has become increasingly widespread. These drugs have been created by manufacturers as an alter- native to already-illegal drugs. This legislation would make W18 illegal in order to prevent the potentially harmful results of W18 from reaching New York.

W-18, which was banned in Canada in 2016, was originally created as a pain reliever and patented in the United States and Canada in 1984, but was only tested on mice and never sold commercially. The 1984 patent for W-18 indicated that there were no tests which could detect the drug in blood or urine. According to the Canadian Department of Health, ."the use of W-18 as a legal substitute for other controlled substances was first detected in Europe in 2013, in the context of recreational use. In 2014,W-18 was added to the Europe an Monitoring Centre for Drugs and Addiction (EMCDDA) list of New Psychoactive Substances." W-18 first appeared in Canada in 2015 in counterfeit oxycodone tablets. Health Canada also indicates that "the high analgesic potency of W-18...suggests a potential severe risk for overdose" and the drug is being imported from drug labs in China.

The Washington Post reported in 2016 that some experts indicate that W-18 is 100 times more potent than fentanyl and 10,000 times stronger than morphine. A portion of W-18 the size of a grain of salt could potentially be deadly, according to WYSR in Syracuse. While more research is needed to prove the level of toxicity in W-18, police departments in Canada indicate that it has been mixed with heroin and cocaine to create a more dangerous synthetic drug.

In March, 2016, a drug dealer in Florida was convicted of smuggling fentanyl and law enforcement found more than 2 1/2 pounds of W-18 at his residence.

Legislative history

Senate

2017-2018- S5112, Referred to Health 2020 - S5221, Referred to Health

2021-2022- S1774, Referred to Health

Assembly 2017-2018- A3030, Referred to Health

2020- A509, Referred to Health

2021-2022- A486, Referred to Health

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.